Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Mesothelioma, Malignant

Pancreatic Intraductal Neoplasms

Brain Neoplasms, Glioblastoma

Carcinoma, Squamous Cell, Neoplasm Metastasis, Recurrence

Nausea, Vomiting, Hematologic Neoplasms

Anticancer Treatment

Small Cell Lung Carcinoma Extensive Disease

Carcinoma, Non-Small-Cell Lung

Leukemia, Leukemia, Myeloid, Acute

Small Cell Lung Carcinoma

Leukemia, Myeloid, Acute, Neoplasm, Residual

Glioblastoma, Recurrence

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

Fallopian Tube Neoplasms, Ovarian Neoplasms

Chemotherapy-induced Neutropenia

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Bile Duct Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Lymphoma, Non-Hodgkin

Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

Melanoma, Neoplasms

Breast Neoplasms

Breast Neoplasms

Ovarian Neoplasms

Breast Neoplasms

Neoplasms, Neuralgia

Breast Neoplasms

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Breast Neoplasms

Prostatic Neoplasms

Clinical Trials

Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer

BELINDA

INFINITE

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer

CSCRGBM

Study of Cemiplimab in Adults With Cervical Cancer

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

AURA3

Durvalumab Plus Chemotherapy in ES-SCLC (Oriental)

A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer

QuANTUM-First

Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients

A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)

Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

JAVELIN OVARIAN PARP100

NEUGR-003

Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia

Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)

MabCute

DeCIDE

GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma

S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo

CALOR

Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE)

PERCHE

A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients

A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA)

A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer.

A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations

THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy